BamSEC and AlphaSense Join Forces
Learn More

bioAffinity Technologies Inc.

NASDAQ: BIAF    
Share price (11/22/24): $1.22    
Market cap (11/22/24): $19.0 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 2 pages Support Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 13 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 3 pages August 21, 2024 Scope of Work and Services
12/34/56
EX-10.3
from 8-K 3 pages Support Agreement
12/34/56
EX-10.2
from 8-K 5 pages August 2, 2024 To: Holder of Common Share Purchase Warrants Re: Inducement Offer and Agreement to Exercise Common Share Purchase Warrants
12/34/56
EX-10.1
from 8-K 31 pages Form of Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 32 pages BioAffinity Technologies, Inc. 2024 Equity Incentive Compensation Plan
12/34/56
EX-10.2
from 8-K 3 pages Support Agreement
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K ~1 page Amendment to Offer Letter
12/34/56
EX-10.1
from 8-K 5 pages BioAffinity Technologies, Inc. Management Incentive Bonus Plan
12/34/56
EX-10.1
from 8-K 1 page December 1, 2023 Dr. Jamie Platt DR.JAMIE.PLATT@GMAIL.com Sincerely, Accepted This 1st Day of December, 2023 /S/ Maria Zannes /S/ Jamie Platt Maria Zannes Jamie Platt, Phd Director, President & CEO
12/34/56
EX-10.13
from 8-K 2 pages Bill of Sale
12/34/56
EX-10.12
from 8-K 19 pages Strategic Relationship and License Agreement
12/34/56
EX-10.11
from 8-K 13 pages Material contract
12/34/56
EX-10.10
from 8-K 22 pages Material contract
12/34/56
EX-10.9
from 8-K 2 pages Assignment and Assumption Agreement
12/34/56
EX-10.8
from 8-K 23 pages Office Lease
12/34/56
EX-10.7
from 8-K 3 pages Assignment and Assumption of Lease Agreement
12/34/56